SEC Filing Summary: India Globalization Capital, Inc. (IGC Pharma, Inc.)
Business Context and Reporting Period
This Form 8-K, dated September 12, 2014, reports on the reconvened 2014 Annual Meeting of Stockholders for India Globalization Capital, Inc. (also referred to as IGC Pharma, Inc. in the request metadata). The meeting was adjourned from August 25, 2014, to allow additional time for stockholder voting on key proposals.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on corporate governance actions and voting results.
Material Changes and Corporate Actions
- Share Issuance Approval: Shareholders approved the issuance of up to 2,000,000 shares of common stock to Bricoleur Partners, L.P., to be used for the payment of principal and/or interest under a Note and Share Purchase Agreement.
- Executive and Director Compensation: Shareholders approved the grant of 1,000,000 shares to the Chief Executive Officer and 500,000 shares to two directors based on performance metrics.
- Board Election: Sudhakar Shenoy was elected to the Board of Directors as a Class A director.
- Auditor Ratification: The appointment of AJSH & Company as the independent registered public accounting firm for the 2015 fiscal year was ratified.
- Say-on-Pay Frequency: Shareholders approved setting the frequency of say-on-pay votes to every three years.
Voting Results
A total of 10,208,873 shares were voted, representing approximately 89.32% of the 11,429,010 shares outstanding. All proposals were approved by the requisite vote.
| Proposal | For Votes | Against Votes | Abstain |
|---|---|---|---|
| Election of Sudhakar Shenoy | 6,275,850 | 122,720 (Withheld) | N/A |
| Ratify Auditor (AJSH & Company) | 9,687,073 | 470,130 | 51,670 |
| Issue 2M Shares to Bricoleur Partners | 5,811,809 | 561,422 | 25,339 |
| Executive Compensation (Say-on-Pay) | 5,819,147 | 533,124 | 46,299 |
| Grant Shares to CEO and Directors | 5,737,240 | 649,131 | 12,199 |
Outlook and Risks
The filing does not contain forward-looking guidance, management commentary on financial outlook, or specific risk factors beyond the implications of the approved share issuances and debt repayment arrangements.
Investor Verification Checklist
- Verify the terms of the Note and Share Purchase Agreement with Bricoleur Partners, L.P., specifically regarding the conversion mechanics of the 2,000,000 approved shares.
- Review the specific performance metrics established by the Board for the 1,000,000 shares granted to the CEO and the 500,000 shares granted to directors.
- Confirm the total outstanding share count post-issuance to assess potential dilution impact.
- Check subsequent filings for the actual execution of the share issuances approved in this meeting.